DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. 1985

A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton

A total of 167 patients undergoing investigation for suspected coronary artery disease (CAD) were genotyped for restriction fragment length polymorphisms (RFLP) at the apo A-1/C-III locus and the insulin gene locus using cloned human apo A-1 and insulin gene probes. The study group was subdivided into patients with absent or minimal CAD, intermediate CAD and severe obstructive CAD. An Sst-1 polymorphism located in the 3' non-coding region of the apo C-III gene identifies two alleles. One of the alleles (S2) showed a significantly increased frequency in the subjects with severe obstructive CAD (18%) compared with patients with minimal or absent CAD (6%) (P less than 0.025) and normolipidaemic control subjects. This A-1/C-III polymorphism may be a marker for an abnormality in the A-1/C-III genes predisposing to atherosclerosis. In contrast to a previous report, we found no increase in the frequency of the Class 3 insulin alleles in subjects with severe CAD.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
July 1987, Atherosclerosis,
A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
March 1988, Clinical science (London, England : 1979),
A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
November 1985, Lancet (London, England),
A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
January 1984, Agents and actions. Supplements,
A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
August 1985, Lancet (London, England),
A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
August 1984, Lancet (London, England),
A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
April 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
August 1988, Atherosclerosis,
A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
May 1992, The Clinical investigator,
A Rees, and J Stocks, and L G Williams, and J L Caplin, and N I Jowett, and A J Camm, and D J Galton
January 2021, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis,
Copied contents to your clipboard!